As of 2026-05-27, the Relative Valuation of Austar Lifesciences Ltd (6118.HK) is 3.20 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 0.78 HKD, the upside of Austar Lifesciences Ltd based on Relative Valuation is 309.8%.
The range of the Relative Valuation is 1.83 - 5.24 HKD.
| Range | Selected | |
| Trailing P/E multiples | 24.1x - 36.5x | 25.8x |
| Forward P/E multiples | 33.7x - 54.9x | 46.4x |
| Fair Price | 1.83 - 5.24 | 3.20 |
| Upside | 134.5% - 571.7% | 309.8% |
| Date | P/E |
| 2026-05-26 | 80.39 |
| 2026-05-22 | 82.46 |
| 2026-05-21 | 83.49 |
| 2026-05-20 | 83.49 |
| 2026-05-19 | 82.46 |
| 2026-05-18 | 82.46 |
| 2026-05-15 | 82.46 |
| 2026-05-14 | 82.46 |
| 2026-05-13 | 82.46 |
| 2026-05-12 | 81.42 |
| 2026-05-11 | 84.52 |
| 2026-05-08 | 84.52 |
| 2026-05-07 | 85.55 |
| 2026-05-06 | 84.52 |
| 2026-05-05 | 83.49 |
| 2026-05-04 | 81.42 |
| 2026-04-30 | 82.46 |
| 2026-04-29 | 79.36 |
| 2026-04-28 | 79.36 |
| 2026-04-27 | 82.46 |
| 2026-04-24 | 82.46 |
| 2026-04-23 | 82.46 |
| 2026-04-22 | 85.55 |
| 2026-04-21 | 85.55 |
| 2026-04-20 | 83.49 |
| 2026-04-17 | 83.49 |
| 2026-04-16 | 83.49 |
| 2026-04-15 | 87.61 |
| 2026-04-14 | 82.46 |
| 2026-04-13 | 82.46 |
| 2026-04-10 | 82.46 |
| 2026-04-09 | 86.58 |
| 2026-04-08 | 84.52 |
| 2026-04-02 | 82.46 |
| 2026-04-01 | 82.46 |
| 2026-03-31 | 84.52 |
| 2026-03-30 | 83.49 |
| 2026-03-27 | 83.49 |
| 2026-03-26 | 74.21 |
| 2026-03-25 | 74.21 |
| 2026-03-24 | 74.21 |
| 2026-03-23 | 69.06 |
| 2026-03-20 | 74.21 |
| 2026-03-19 | 72.15 |
| 2026-03-18 | 73.18 |
| 2026-03-17 | 77.30 |
| 2026-03-16 | 77.30 |
| 2026-03-13 | 77.30 |
| 2026-03-12 | 75.24 |
| 2026-03-11 | 78.33 |